Skip to content
Optellum
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales
Menu Close
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

News & Events

Read more about the article Optellum, Johnson & Johnson Launch Strategic Collaboration in Lung Cancer

Optellum, Johnson & Johnson Launch Strategic Collaboration in Lung Cancer

  • Post published:September 26, 2021
  • Post category:Media

Onclive

Continue ReadingOptellum, Johnson & Johnson Launch Strategic Collaboration in Lung Cancer
Read more about the article Biopharma AI Collaborations Driving Innovative Change in Drug Development

Biopharma AI Collaborations Driving Innovative Change in Drug Development

  • Post published:September 13, 2021
  • Post category:Media

BioSpace

Continue ReadingBiopharma AI Collaborations Driving Innovative Change in Drug Development
Read more about the article Biopharma AI Collaborations Driving Innovative Change in Drug Development

Biopharma AI Collaborations Driving Innovative Change in Drug Development

  • Post published:September 13, 2021
  • Post category:Media

BioPharmaLive

Continue ReadingBiopharma AI Collaborations Driving Innovative Change in Drug Development
Read more about the article J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

  • Post published:August 26, 2021
  • Post category:Media

PharmaPhorum is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.PharmaPhorum

Continue ReadingJ&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
Read more about the article J&J teams up with Optellum to improve lung cancer survival rates

J&J teams up with Optellum to improve lung cancer survival rates

  • Post published:August 26, 2021
  • Post category:Media

EPM’s in-depth journalism drives the conversation on topics shaping the pharma and biopharma industries, from clinical trial to mass production, regulations, and logistics and distribution. EPM delivers the insight, news,…

Continue ReadingJ&J teams up with Optellum to improve lung cancer survival rates
Read more about the article Optellum collaborating with J&J

Optellum collaborating with J&J

  • Post published:August 23, 2021
  • Post category:Media

Thames Valley BiotechNewsletter

Continue ReadingOptellum collaborating with J&J
Read more about the article Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

  • Post published:August 23, 2021
  • Post category:Media

Founded in 2012, HIT Consultant is the leading source of healthcare technology news, analysis and insights for healthcare executives, physicians, and providers. Our content provides editorial insights on health IT,…

Continue ReadingOptellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative
Read more about the article Optellum Joins J&J’s Lung Cancer Initiative

Optellum Joins J&J’s Lung Cancer Initiative

  • Post published:August 23, 2021
  • Post category:Media

Reporter: Reed Miller reed.miller@informa.comMedTech Insight

Continue ReadingOptellum Joins J&J’s Lung Cancer Initiative
Read more about the article Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Today UK News Reporter: Debbie Casey

Continue ReadingOptellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Read more about the article EIT Health-supported Optellum partners with J&J

EIT Health-supported Optellum partners with J&J

  • Post published:August 20, 2021
  • Post category:Media

EIT Health

Continue ReadingEIT Health-supported Optellum partners with J&J
Read more about the article Health Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

Health Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Health Tech Digital

Continue ReadingHealth Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Read more about the article Emintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment

Emintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Emintera

Continue ReadingEmintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment
  • 1
  • 2
  • 3
  • 4
  • Go to the next page

Optellum Ltd.

  • Oxford Centre for Innovation
    Oxford, OX1 1BY
    United Kingdom
  • info@optellum.comOpens in your application

Optellum Inc.

  • TMC Innovation Institute
    2450 Holcombe Blvd, Suite X
    Houston, TX 77021
    United States

Pages

  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

Follow Us

  • Opens in a new tab
  • Opens in a new tab

Certifications

Copyright 2023 - Optellum Ltd | Privacy Policy
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}